PMC:7534795 / 21078-21247 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T26125","span":{"begin":13,"end":21},"obj":"Body_part"}],"attributes":[{"id":"A95416","pred":"fma_id","subj":"T26125","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":" to mitigate cytokine storm • Prospective observational study\n• Severe or critical COVID-19 infection\n• 25 to 88 years of age\n• N = 21 tocilizumab + standard therapy\n• "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T183","span":{"begin":83,"end":91},"obj":"Disease"},{"id":"T184","span":{"begin":92,"end":101},"obj":"Disease"}],"attributes":[{"id":"A183","pred":"mondo_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A184","pred":"mondo_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":" to mitigate cytokine storm • Prospective observational study\n• Severe or critical COVID-19 infection\n• 25 to 88 years of age\n• N = 21 tocilizumab + standard therapy\n• "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T151","span":{"begin":136,"end":147},"obj":"Chemical"}],"attributes":[{"id":"A151","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":" to mitigate cytokine storm • Prospective observational study\n• Severe or critical COVID-19 infection\n• 25 to 88 years of age\n• N = 21 tocilizumab + standard therapy\n• "}

{"project":"LitCovid-sentences","denotations":[{"id":"T137","span":{"begin":62,"end":101},"obj":"Sentence"},{"id":"T138","span":{"begin":102,"end":125},"obj":"Sentence"},{"id":"T139","span":{"begin":126,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" to mitigate cytokine storm • Prospective observational study\n• Severe or critical COVID-19 infection\n• 25 to 88 years of age\n• N = 21 tocilizumab + standard therapy\n• "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T88","span":{"begin":13,"end":27},"obj":"Phenotype"}],"attributes":[{"id":"A88","pred":"hp_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":" to mitigate cytokine storm • Prospective observational study\n• Severe or critical COVID-19 infection\n• 25 to 88 years of age\n• N = 21 tocilizumab + standard therapy\n• "}

{"project":"LitCovid-PubTator","denotations":[{"id":"687","span":{"begin":83,"end":91},"obj":"Disease"}],"attributes":[{"id":"A687","pred":"tao:has_database_id","subj":"687","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" to mitigate cytokine storm • Prospective observational study\n• Severe or critical COVID-19 infection\n• 25 to 88 years of age\n• N = 21 tocilizumab + standard therapy\n• "}